Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
announced the decision to discontinue the development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated for chronic weight management
Analogues : Modified versions of naturally occurring molecules (like peptides or hormones) designed to improve stability, potency, or duration of action
Hunger and food noise tend to return mildly within 4-7 days of a missed injection because drug levels dip below the peak
Nausea and vomiting were noted among the monitored outcomes, consistent with what any gastrointestinal intervention in post-surgical patients would produce
US$ 20.44
US$ 23.14
US$ 21.77
US$ 27.37
US$ 29.57
